JAK2 and lung carcinoma: These findings point to LPA1/MAPK and JAK2/STAT3 axes as important regulators of human lung cancer cell dissemination, and suggest that targeting PA formation and/or the LPA1 receptor may provide new strategies to reduce malignancy in lung cancer.